Overexpression of Type 2 Iodothyronine Deiodinase in Follicular Carcinoma as a Cause of Low Circulating Free Thyroxine Levels
Thyroid function is normally undisturbed in patients with thyroid carcinoma. We have identified three patients with large or widely metastatic follicular thyroid carcinoma who had a persistently increased ratio of serum T3 to T4 in the absence of autonomous production of T3 by the tumor. To investig...
Gespeichert in:
Veröffentlicht in: | The journal of clinical endocrinology and metabolism 2003-02, Vol.88 (2), p.594-598 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 598 |
---|---|
container_issue | 2 |
container_start_page | 594 |
container_title | The journal of clinical endocrinology and metabolism |
container_volume | 88 |
creator | Kim, B. W. Daniels, G. H. Harrison, B. J. Price, A. Harney, J. W. Larsen, P. R. Weetman, A. P. |
description | Thyroid function is normally undisturbed in patients with thyroid carcinoma. We have identified three patients with large or widely metastatic follicular thyroid carcinoma who had a persistently increased ratio of serum T3 to T4 in the absence of autonomous production of T3 by the tumor. To investigate the possibility of tumor-mediated T4 to T3 conversion, we assayed types 1 and 2 iodothyronine selenodeiodinase (D1 and D2) activity in a 965-g follicular thyroid carcinoma resected from one of these patients. The Vmax for D2 was 8-fold higher than in normal human thyroid tissue. Resection of this tumor, leaving the left thyroid lobe intact, normalized the serum T3 to T4 ratio. In two other patients, treatment with sufficient levothyroxine to suppress TSH was associated with a high normal T3 and a subnormal free T4 index. In one, concomitant administration of the D1 inhibitors, propylthiouracil and propranolol, did not decrease the elevated serum T3 to T4 ratio. These data illustrate that increased T4 to T3 conversion in follicular thyroid carcinomas, probably by D2, can cause a significant perturbation in peripheral thyroid hormone concentrations. |
doi_str_mv | 10.1210/jc.2002-020921 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73017883</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>73017883</sourcerecordid><originalsourceid>FETCH-LOGICAL-c367t-f2d196caf93c9b38e5f3046562a3085d9ca0acddb108d5c159d54622b84ded163</originalsourceid><addsrcrecordid>eNp1kT1PGzEYgK2qqISPtWPlpWwX_Hl3HlHaAFIkllTqZjn2e62jix3sHJCB_46PRGJisl758aNXjxH6TsmUMkqu13bKCGEVYUQx-gVNqBKyaqhqvqJJuaCVatjfU3SW85oQKoTk39ApZbIRtK0n6PXhCRK8bBPk7GPAscPL_RYww_fRxd3_fYrBB8C_wEfng8mAfcDz2PfeDr1JeGaS9SFuDDYZmzIOBSmWRXzGM59GaOfDPzxPAHg5-l5G3wKeoM8X6KQzfYbL43mO_sx_L2d31eLh9n52s6gsr5td1TFHVW1Np7hVK96C7DgRtayZ4aSVTllDjHVuRUnrpKVSOSlqxlatcOBozc_R1cG7TfFxgLzTG58t9L0JEIesG05o07a8gNMDaFPMOUGnt8lvTNprSvQYXK-tHoPrQ_Dy4MfRPKw24D7wY-EC_DwCJlvTd8kE6_MHJ6RgTTuK5IGD4KJNpdH7n-h1HFIobT5b4A24k5ss</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73017883</pqid></control><display><type>article</type><title>Overexpression of Type 2 Iodothyronine Deiodinase in Follicular Carcinoma as a Cause of Low Circulating Free Thyroxine Levels</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Oxford University Press Journals All Titles (1996-Current)</source><creator>Kim, B. W. ; Daniels, G. H. ; Harrison, B. J. ; Price, A. ; Harney, J. W. ; Larsen, P. R. ; Weetman, A. P.</creator><creatorcontrib>Kim, B. W. ; Daniels, G. H. ; Harrison, B. J. ; Price, A. ; Harney, J. W. ; Larsen, P. R. ; Weetman, A. P.</creatorcontrib><description>Thyroid function is normally undisturbed in patients with thyroid carcinoma. We have identified three patients with large or widely metastatic follicular thyroid carcinoma who had a persistently increased ratio of serum T3 to T4 in the absence of autonomous production of T3 by the tumor. To investigate the possibility of tumor-mediated T4 to T3 conversion, we assayed types 1 and 2 iodothyronine selenodeiodinase (D1 and D2) activity in a 965-g follicular thyroid carcinoma resected from one of these patients. The Vmax for D2 was 8-fold higher than in normal human thyroid tissue. Resection of this tumor, leaving the left thyroid lobe intact, normalized the serum T3 to T4 ratio. In two other patients, treatment with sufficient levothyroxine to suppress TSH was associated with a high normal T3 and a subnormal free T4 index. In one, concomitant administration of the D1 inhibitors, propylthiouracil and propranolol, did not decrease the elevated serum T3 to T4 ratio. These data illustrate that increased T4 to T3 conversion in follicular thyroid carcinomas, probably by D2, can cause a significant perturbation in peripheral thyroid hormone concentrations.</description><identifier>ISSN: 0021-972X</identifier><identifier>EISSN: 1945-7197</identifier><identifier>DOI: 10.1210/jc.2002-020921</identifier><identifier>PMID: 12574186</identifier><identifier>CODEN: JCEMAZ</identifier><language>eng</language><publisher>Bethesda, MD: Endocrine Society</publisher><subject>Adenocarcinoma, Follicular - blood ; Adenocarcinoma, Follicular - enzymology ; Adenocarcinoma, Follicular - surgery ; Adult ; Aged ; Biological and medical sciences ; Endocrinopathies ; Humans ; Iodide Peroxidase - metabolism ; Iodothyronine Deiodinase Type II ; Male ; Malignant tumors ; Medical sciences ; Thyroid Neoplasms - blood ; Thyroid Neoplasms - enzymology ; Thyroid Neoplasms - surgery ; Thyroid Nodule - blood ; Thyroid Nodule - enzymology ; Thyroid Nodule - surgery ; Thyroid. Thyroid axis (diseases) ; Thyroxine - blood</subject><ispartof>The journal of clinical endocrinology and metabolism, 2003-02, Vol.88 (2), p.594-598</ispartof><rights>2003 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c367t-f2d196caf93c9b38e5f3046562a3085d9ca0acddb108d5c159d54622b84ded163</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14542781$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12574186$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kim, B. W.</creatorcontrib><creatorcontrib>Daniels, G. H.</creatorcontrib><creatorcontrib>Harrison, B. J.</creatorcontrib><creatorcontrib>Price, A.</creatorcontrib><creatorcontrib>Harney, J. W.</creatorcontrib><creatorcontrib>Larsen, P. R.</creatorcontrib><creatorcontrib>Weetman, A. P.</creatorcontrib><title>Overexpression of Type 2 Iodothyronine Deiodinase in Follicular Carcinoma as a Cause of Low Circulating Free Thyroxine Levels</title><title>The journal of clinical endocrinology and metabolism</title><addtitle>J Clin Endocrinol Metab</addtitle><description>Thyroid function is normally undisturbed in patients with thyroid carcinoma. We have identified three patients with large or widely metastatic follicular thyroid carcinoma who had a persistently increased ratio of serum T3 to T4 in the absence of autonomous production of T3 by the tumor. To investigate the possibility of tumor-mediated T4 to T3 conversion, we assayed types 1 and 2 iodothyronine selenodeiodinase (D1 and D2) activity in a 965-g follicular thyroid carcinoma resected from one of these patients. The Vmax for D2 was 8-fold higher than in normal human thyroid tissue. Resection of this tumor, leaving the left thyroid lobe intact, normalized the serum T3 to T4 ratio. In two other patients, treatment with sufficient levothyroxine to suppress TSH was associated with a high normal T3 and a subnormal free T4 index. In one, concomitant administration of the D1 inhibitors, propylthiouracil and propranolol, did not decrease the elevated serum T3 to T4 ratio. These data illustrate that increased T4 to T3 conversion in follicular thyroid carcinomas, probably by D2, can cause a significant perturbation in peripheral thyroid hormone concentrations.</description><subject>Adenocarcinoma, Follicular - blood</subject><subject>Adenocarcinoma, Follicular - enzymology</subject><subject>Adenocarcinoma, Follicular - surgery</subject><subject>Adult</subject><subject>Aged</subject><subject>Biological and medical sciences</subject><subject>Endocrinopathies</subject><subject>Humans</subject><subject>Iodide Peroxidase - metabolism</subject><subject>Iodothyronine Deiodinase Type II</subject><subject>Male</subject><subject>Malignant tumors</subject><subject>Medical sciences</subject><subject>Thyroid Neoplasms - blood</subject><subject>Thyroid Neoplasms - enzymology</subject><subject>Thyroid Neoplasms - surgery</subject><subject>Thyroid Nodule - blood</subject><subject>Thyroid Nodule - enzymology</subject><subject>Thyroid Nodule - surgery</subject><subject>Thyroid. Thyroid axis (diseases)</subject><subject>Thyroxine - blood</subject><issn>0021-972X</issn><issn>1945-7197</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kT1PGzEYgK2qqISPtWPlpWwX_Hl3HlHaAFIkllTqZjn2e62jix3sHJCB_46PRGJisl758aNXjxH6TsmUMkqu13bKCGEVYUQx-gVNqBKyaqhqvqJJuaCVatjfU3SW85oQKoTk39ApZbIRtK0n6PXhCRK8bBPk7GPAscPL_RYww_fRxd3_fYrBB8C_wEfng8mAfcDz2PfeDr1JeGaS9SFuDDYZmzIOBSmWRXzGM59GaOfDPzxPAHg5-l5G3wKeoM8X6KQzfYbL43mO_sx_L2d31eLh9n52s6gsr5td1TFHVW1Np7hVK96C7DgRtayZ4aSVTllDjHVuRUnrpKVSOSlqxlatcOBozc_R1cG7TfFxgLzTG58t9L0JEIesG05o07a8gNMDaFPMOUGnt8lvTNprSvQYXK-tHoPrQ_Dy4MfRPKw24D7wY-EC_DwCJlvTd8kE6_MHJ6RgTTuK5IGD4KJNpdH7n-h1HFIobT5b4A24k5ss</recordid><startdate>20030201</startdate><enddate>20030201</enddate><creator>Kim, B. W.</creator><creator>Daniels, G. H.</creator><creator>Harrison, B. J.</creator><creator>Price, A.</creator><creator>Harney, J. W.</creator><creator>Larsen, P. R.</creator><creator>Weetman, A. P.</creator><general>Endocrine Society</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20030201</creationdate><title>Overexpression of Type 2 Iodothyronine Deiodinase in Follicular Carcinoma as a Cause of Low Circulating Free Thyroxine Levels</title><author>Kim, B. W. ; Daniels, G. H. ; Harrison, B. J. ; Price, A. ; Harney, J. W. ; Larsen, P. R. ; Weetman, A. P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c367t-f2d196caf93c9b38e5f3046562a3085d9ca0acddb108d5c159d54622b84ded163</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Adenocarcinoma, Follicular - blood</topic><topic>Adenocarcinoma, Follicular - enzymology</topic><topic>Adenocarcinoma, Follicular - surgery</topic><topic>Adult</topic><topic>Aged</topic><topic>Biological and medical sciences</topic><topic>Endocrinopathies</topic><topic>Humans</topic><topic>Iodide Peroxidase - metabolism</topic><topic>Iodothyronine Deiodinase Type II</topic><topic>Male</topic><topic>Malignant tumors</topic><topic>Medical sciences</topic><topic>Thyroid Neoplasms - blood</topic><topic>Thyroid Neoplasms - enzymology</topic><topic>Thyroid Neoplasms - surgery</topic><topic>Thyroid Nodule - blood</topic><topic>Thyroid Nodule - enzymology</topic><topic>Thyroid Nodule - surgery</topic><topic>Thyroid. Thyroid axis (diseases)</topic><topic>Thyroxine - blood</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kim, B. W.</creatorcontrib><creatorcontrib>Daniels, G. H.</creatorcontrib><creatorcontrib>Harrison, B. J.</creatorcontrib><creatorcontrib>Price, A.</creatorcontrib><creatorcontrib>Harney, J. W.</creatorcontrib><creatorcontrib>Larsen, P. R.</creatorcontrib><creatorcontrib>Weetman, A. P.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The journal of clinical endocrinology and metabolism</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kim, B. W.</au><au>Daniels, G. H.</au><au>Harrison, B. J.</au><au>Price, A.</au><au>Harney, J. W.</au><au>Larsen, P. R.</au><au>Weetman, A. P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Overexpression of Type 2 Iodothyronine Deiodinase in Follicular Carcinoma as a Cause of Low Circulating Free Thyroxine Levels</atitle><jtitle>The journal of clinical endocrinology and metabolism</jtitle><addtitle>J Clin Endocrinol Metab</addtitle><date>2003-02-01</date><risdate>2003</risdate><volume>88</volume><issue>2</issue><spage>594</spage><epage>598</epage><pages>594-598</pages><issn>0021-972X</issn><eissn>1945-7197</eissn><coden>JCEMAZ</coden><abstract>Thyroid function is normally undisturbed in patients with thyroid carcinoma. We have identified three patients with large or widely metastatic follicular thyroid carcinoma who had a persistently increased ratio of serum T3 to T4 in the absence of autonomous production of T3 by the tumor. To investigate the possibility of tumor-mediated T4 to T3 conversion, we assayed types 1 and 2 iodothyronine selenodeiodinase (D1 and D2) activity in a 965-g follicular thyroid carcinoma resected from one of these patients. The Vmax for D2 was 8-fold higher than in normal human thyroid tissue. Resection of this tumor, leaving the left thyroid lobe intact, normalized the serum T3 to T4 ratio. In two other patients, treatment with sufficient levothyroxine to suppress TSH was associated with a high normal T3 and a subnormal free T4 index. In one, concomitant administration of the D1 inhibitors, propylthiouracil and propranolol, did not decrease the elevated serum T3 to T4 ratio. These data illustrate that increased T4 to T3 conversion in follicular thyroid carcinomas, probably by D2, can cause a significant perturbation in peripheral thyroid hormone concentrations.</abstract><cop>Bethesda, MD</cop><pub>Endocrine Society</pub><pmid>12574186</pmid><doi>10.1210/jc.2002-020921</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0021-972X |
ispartof | The journal of clinical endocrinology and metabolism, 2003-02, Vol.88 (2), p.594-598 |
issn | 0021-972X 1945-7197 |
language | eng |
recordid | cdi_proquest_miscellaneous_73017883 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Oxford University Press Journals All Titles (1996-Current) |
subjects | Adenocarcinoma, Follicular - blood Adenocarcinoma, Follicular - enzymology Adenocarcinoma, Follicular - surgery Adult Aged Biological and medical sciences Endocrinopathies Humans Iodide Peroxidase - metabolism Iodothyronine Deiodinase Type II Male Malignant tumors Medical sciences Thyroid Neoplasms - blood Thyroid Neoplasms - enzymology Thyroid Neoplasms - surgery Thyroid Nodule - blood Thyroid Nodule - enzymology Thyroid Nodule - surgery Thyroid. Thyroid axis (diseases) Thyroxine - blood |
title | Overexpression of Type 2 Iodothyronine Deiodinase in Follicular Carcinoma as a Cause of Low Circulating Free Thyroxine Levels |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T14%3A19%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Overexpression%20of%20Type%202%20Iodothyronine%20Deiodinase%20in%20Follicular%20Carcinoma%20as%20a%20Cause%20of%20Low%20Circulating%20Free%20Thyroxine%20Levels&rft.jtitle=The%20journal%20of%20clinical%20endocrinology%20and%20metabolism&rft.au=Kim,%20B.%20W.&rft.date=2003-02-01&rft.volume=88&rft.issue=2&rft.spage=594&rft.epage=598&rft.pages=594-598&rft.issn=0021-972X&rft.eissn=1945-7197&rft.coden=JCEMAZ&rft_id=info:doi/10.1210/jc.2002-020921&rft_dat=%3Cproquest_cross%3E73017883%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=73017883&rft_id=info:pmid/12574186&rfr_iscdi=true |